⌘K

Login Start Free

Home/Filings/4/0001209191-20-039144

4//SEC Filing

Lam Karen C 4

Accession 0001209191-20-039144

CIK 0001673772other

View on SEC.gov Company Profile

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 5:46 PM ET

Size

4.8 KB

Accession

0001209191-20-039144

Insider Transaction Report

Form 4

Period: 2020-06-25

RAPT Therapeutics, Inc.RAPT

VP, Finance & Controller

Transactions

Sale
Common Stock
2020-06-25$35.00/sh−875$30,625→ 12,735 total

Footnotes (1)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2020.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

RAPT Therapeutics, Inc.

CIK 0001673772

Entity typeother

Related Parties

1

filerCIK 0001783296

Filing Metadata

Form type: 4
Filed: Jun 25, 8:00 PM ET
Accepted: Jun 26, 5:46 PM ET
Size: 4.8 KB

View on SEC.gov